ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- Wall St futures slip as oil surge puts markets on edge
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
ResMed (RMD) Tops Q4 EPS by 7c
August 5, 2021 4:09 PM EDTResMed (NYSE: RMD) reported Q4 EPS of $1.35, $0.07 better than the analyst estimate of $1.28. Revenue for the quarter came in at $876.1 million versus the consensus estimate of $783.18 million.
Our fourth quarter and full-year fiscal year 2021 results continue to demonstrate the strength and resiliency of our business, said Mick Farrell, ResMeds CEO. During the quarter, we saw the ongoing recovery of core sleep apnea and COPD patient flow across... More
